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with greater depressive symptom severity (r = 0.624, p < 
0.01) as well as with higher concentrations of CgA (r = 0.660, 
p < 0.01), LL-37 (r = 0.643, p < 0.01), IL-6 (r = 0.532, p < 0.05) 
and CRP (r = 0.470, p < 0.05). BDI scores associated with CgA 
concentration (r = 0.618, p < 0.01) and CgA level correlated 
negatively with the social support score (r = –0.511, p < 0.05). 
 Conclusions: Our findings suggest that, in patients with sta-
ble CAD, elevated MLR may be associated with depressive 
symptoms, with increased neuroendocrine-sympathetic ac-
tivity (marked by CgA) and inflammatory markers that are 
pertinent to atherosclerosis initiation and progression. The 
increased neuroendocrine-sympathetic activity correlated 
with low social support and depressive symptom severity. 
The MLR might serve as an easy-to-obtain and inexpensive 
proxy measure of an activated PNI network in stable CAD. 
 © 2016 S. Karger AG, Basel 
 Introduction 
 Psychological stress and depression are increasingly 
recognized as major risk factors for the incidence of coro-
nary artery disease (CAD) as well as independent predic-
tors of poor cardiac prognosis  [1–5] . Stress has been sug-
gested to lead to both depression and CAD  [2] . While 
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 Abstract 
 Background: Psychosocial stress and depression have been 
recognized as major risk factors of coronary artery disease 
(CAD). Although monocytes are known to be key players in 
atherosclerosis, monocyte-based associations with psycho-
neuroendocrino-immuno-inflammatory (PNI) markers have 
not been widely investigated in stable CAD.  Objective: We 
examined associations between the monocyte-to-lympho-
cyte ratio (MLR) and key PNI markers in stable CAD.  Methods: 
We studied 23 patients with stable CAD who completed the 
Beck Depression Inventory (BDI) and Rahe’s Brief Stress and 
Coping Inventory. A white blood cell differential was per-
formed, and levels of cortisol, chromogranin A (CgA), LL-37, 
interleukin-6 (IL-6) and C-reactive protein (CRP) were as-
sayed in plasma.  Results: Monocyte fraction, MLR and plas-
ma CgA levels exceeded reference values, the social support 
score was low, and 7 patients had elevated BDI scores. In the 
multivariate-adjusted analysis, a higher MLR was associated 
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social isolation and a lack of social support are also risk 
factors for CAD, low ‘meaning of life’ (life meaning) 
scores might increase the risk of CAD mortality  [1, 5–7] . 
The sympathetic-adrenomedullary system and the hypo-
thalamic-pituitary-adrenocortical (HPA) axis critically 
govern the stress response. To some extent, plasma corti-
sol levels indicate HPA axis activity and plasma chromo-
granin A (CgA) levels reflect neuroendocrine and sympa-
thoadrenal activity  [8, 9] .
 Cytokines are key players of the psycho-neuroendo-
crine-/immuno-inflammatory (PNI) system; they exert a 
critical, early role in atherogenesis  [1] . IL-6 is a main reg-
ulator of the systemic inflammatory response and induc-
es the acute-phase reaction during which C-reactive pro-
tein (CRP) is synthesized by the liver as well as being a 
highly potent stimulator of the HPA axis  [10, 11] . Both 
IL-6 and CRP are major markers of vascular inflamma-
tion in CAD  [12] , and their plasma concentrations are 
increased in individuals with psychosocial stress and de-
pression  [13, 14] . Another key but less investigated in-
flammatory marker is LL-37 that is typically produced by 
macrophages in atherosclerotic lesions  [15, 16] .
 Both neutrophils and macrophages (mostly derived 
from monocytes) have fundamental roles in the forma-
tion and progression of coronary atherosclerotic plaques 
 [17–19] . Several studies found that high neutrophil count 
or neutrophil-to-lymphocyte ratio are characteristic for 
coronary stenosis and could predict CAD and major ad-
verse cardiac events, including myocardial infarction 
 [20–25] . Waterhouse et al.  [26] , however, have shown 
that of all leukocyte types, the monocyte count has the 
strongest positive and independent relationship with 
CAD risk in asymptomatic adults. In addition, the mono-
cyte count predicted the severity of atherosclerotic steno-
sis and plaque progression in acute coronary syndromes 
 [24, 27] . In contrast, in patients with acute chest pain, a 
low lymphocyte count was indicative of an increased risk 
of developing myocardial infarction and all-cause mor-
tality  [28] . A decreased lymphocyte-to-monocyte ratio 
correlated with CAD and prior myocardial infarction in 
addition to a high risk for critical limb ischemia  [29] . As 
yet, only a few studies have analyzed associations between 
monocyte counts/fractions and psychological factors. In 
patients with acute coronary syndrome, a higher mono-
cyte fraction was found to be associated with less social 
support and more life-event stress  [30] .
 The primary aim of our study was to investigate the 
association of the monocyte-to-lymphocyte ratio (MLR) 
with psychosocial factors and neuroendocrino-inflam-
matory markers in patients with stable CAD. To our 
knowledge, such correlations have not previously been 
studied. Specifically, we hypothesized significant associa-
tions of the MLR with depressive symptoms, stress and 
coping scores as well as with the circulating levels of cor-
tisol, CgA, IL-6, CRP and LL-37 in patients with stable 
angina pectoris. A secondary aim was to perform correla-
tion analyses of psychosocial factors and neuroendocrine 
and inflammatory markers.
 Methods 
 Patients 
 Twenty-three patients with stable CAD participated in our 
study. For inclusion, significant stenosis of at least 2 major coro-
nary arteries was to be demonstrated by coronary angiography 
(significant diameter stenosis >50%). Exclusion criteria included 
bypass surgery, cardiogenic shock, malignancy (e.g. prostate can-
cer), any immunological disorders (including rheumatoid arthritis 
and chronic atrophic gastritis type A) or acute inflammations,
immunosuppressive/anti-inflammatory medication (except low-
dose aspirin), recent major trauma/surgery, impaired renal func-
tion and drug/alcohol abuse. The severity of heart failure symp-
toms was graded according to the New York Heart Association 
(NYHA) functional classification (grades I–IV).
 Participants provided written consent for conducting the study 
protocol which was approved by the Medical Ethics Committee at 
our Medical Faculty (Human Investigation Review Board, ref. No. 
49/B-125/2008, 2382). The investigation conformed to the prin-
ciples of the Declaration of Helsinki.
 Psychosocial Measures 
 We measured the severity of depressive symptoms with the 21-
item Beck Depression Inventory (BDI)  [31] , using its Hungarian 
version  [32] . Participants rate every item on a scale 0 to 3. Total 
scores indicate no clinically relevant depressive symptoms (0–9), 
mild (10–18), moderate (19–25) and severe (25–63) depressive 
symptoms. 
 To assess everyday stress level and coping capacity, we applied 
Rahe’s Brief Stress and Coping Inventory (BSCI, a multidimen-
sional self-describing device)  [33] . To obtain a global stress-coping 
score, total stress score was subtracted from total coping score. 
Score evaluation was performed according to the validated Hun-
garian version: worrisome/non-sufficient (–15 to –5), sufficient 
(–4 to –1), good (0 to 4) or very good (5 to 15)  [34] . Both the stress 
and coping scales are divided into 5 subscales. Coping subscales 
measure health habits, social support, responses to stress, life sat-
isfaction and ‘purpose and connection’. Specifically, the social sup-
port subscale measures the degree of a participant’s social network. 
The purpose and connection subscale (also called meaning of/in 
life or ‘life meaning’) reflects to what extent subjects feel their life 
is ‘worth living’  [7] . Subscale scores range from 0 to 14 (social sup-
port) or 0 to 16 (life meaning), and coping with stress is indicated 
as worrisome/non-sufficient (0–7), sufficient (8–10), good (11–
13) or very good/excellent (14–16).
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 Blood Sampling and Laboratory Assays 
 Fasting venous blood samples were collected 1 day before cor-
onary angiography between 7 and 10 a.m. Blood counts, total cho-
lesterol, triglycerides, high-density lipoprotein (HDL)-cholesterol 
and high-sensitivity (hs)-CRP were determined in automatic ana-
lyzers and/or using commercial kits (Roche); low-density lipopro-
tein (LDL)-cholesterol was calculated according to the Friedewald 
formula. Since no reference interval was available for the MLR, we 
used the ratio of the median values of the monocyte and lympho-
cyte reference ranges (counts) as a reference: 0.19.
 For the assessment of plasma levels of CgA, cortisol, LL-37 and 
IL-6, we collected blood into cooled (4    °    C) EDTA-Vacutainer 
tubes. CgA was assayed with a radioimmunoassay kit (CGA-RIA 
CT, CIS Bio International, Gif-sur-Yvette, France; intra- and in-
terassay CVs: <7%). Cortisol was determined by radioimmunoas-
say (DSL-2100, Diagnostic Systems Laboratories, Webster, Tex., 
USA; intra- and interassay CVs: <12%). LL-37 concentration was 
measured with an ELISA kit (HK321, Hycult Biotech Inc., Uden, 
The Netherlands; intra- and interassay CVs: <10%). Due to techni-
cal problems, LL-37, cortisol and LDL-cholesterol values were not 
available for 1 patient. IL-6 was assayed using a high-sensitivity 
ELISA kit (BMS213HS; Bender MedSystems GmbH, Vienna, Aus-
tria; intra- and interassay CVs: 4.95 and 6.0%, respectively).
 Statistical Analysis 
 We first calculated the necessary sample size to achieve clini-
cally meaningful correlation coefficients of r  ≥ 0.6 between vari-
ables of interest with a power of 80% and a 5% level of significance. 
The power analysis yielded a sample size of 19 patients, and so we 
recruited 24 patients in order to compensate for potential drop-
outs. In fact, 1 patient was transferred to a county hospital before 
being assessed, leaving 23 participants for our study.
 Cohen  [35]  provides guidelines for interpreting the effect size 
of correlation coefficients (r) with values of 0.1, 0.3 and 0.5 as 
small, medium and large, respectively. Therefore, regardless of p 
values, correlation coefficients  ≥ 0.6 may yield spurious findings, 
even when performing multiple tests. Specifically, we did not ad-
just p values for multiple comparisons because of our pre-estab-
lished primary hypothesis that MLR would show significant asso-
ciations with psychosocial factors and neuroendocrine and in-
flammation markers. In this still-nascent field of research, the 
Bonferroni adjustment bears the risk of deeming truly important 
differences non-significant  [36] . Secondary hypotheses were for-
mulated for significant associations amongst psychosocial factors 
and neuroendocrine and inflammation markers (but not MLR) 
 [37] . 
 All statistical analyses were performed using IBM-SPSS soft-
ware, v20.0 (SPSS Inc., Chicago, Ill., USA) with a two-sided sig-
nificance level of p < 0.05. For continuous variables, values are 
presented as mean ± standard deviation (SD). Data that did not 
show a normal distribution (i.e. MLR, CRP and BDI) were log 10 -
transformed before analysis. The Student t test was applied to test 
for differences in psychosocial factors and neuroendocrine and in-
flammatory markers according to sex, diabetes smoking and med-
ications.
 To examine associations of MLR with psychosocial factors and 
neuroendocrine and inflammatory markers, we employed the bi-
variate and multivariate Pearson correlation analyses with adjust-
ment for age, sex and BMI. Similar analyses were performed to 
estimate the correlations amongst psychosocial factors and neuro-
endocrine and inflammatory markers. As proton-pump inhibitors 
could elevate plasma CgA, and CgA levels could also be elevated 
in chronic heart failure, we additionally corrected CgA models for 
intake of this medication and NYHA grades  [38, 39] . As sedative 
use showed a significant relation with BDI scores, we also con-
trolled for this in the models with the BDI. 
 Results 
 Patient Characteristics 
 The study participants were 18 men and 5 women. The 
mean age of the sample was 62.9 ± 10.6 years (range 43–79 
years). Regarding established cardiovascular risk factors, 
our patients were, on average, overweight, with a BMI of 
28.8 ± 4.0. Eight (35%) had diabetes mellitus and 2 (9%) 
were current smokers. There were 3 (13%), 4 (17%) and 
5 (22%) patients in NYHA groups I, II and III, respec-
tively. All of the patients took aspirin, and antihyperten-
sives and statins were taken by 22 (96%) and 21 (91%), 
respectively. Moreover, 16 (70%) were on proton-pump 
inhibitors and 9 (39%) on sedatives. No patients were on 
antidepressants or H 2 -receptor blockers.
 Laboratory Parameters: MLR and Neuroendocrine 
and Inflammatory Factors 
 As can be seen in  table 1 , the monocyte fraction (8.68%, 
SD 2.97) exceeded the maximal reference value (7%), and 
monocyte count approached the upper reference limit, 
while the lymphocyte fraction was close to the minimal 
reference value. Thus, the MLR yielded a relatively high 
value of 0.32 (SD 0.14), exceeding the predefined refer-
ence value of 0.19. Normal values were observed for the 
other white blood cells (shown: total leukocyte count, 
neutrophil count and fraction) and blood lipids, except 
for slightly elevated triglyceride levels. Of the neuroendo-
crine and inflammatory parameters, only CgA was out-
side the reference range, exceeding the upper reference 
value as per the recent literature  [40] . CRP was close to its 
upper reference limit.
 Psychosocial Factors 
 While the average depressive symptom level of our 
participants was in the subclinical range, 7 (30%) had BDI 
scores that indicated clinically relevant depressive symp-
toms, i.e. 5 with mild symptoms, 1 with moderate symp-
toms and 1 with severe symptoms. Nonetheless, a sub-
group analysis showed significantly higher BDI scores in 
patients on sedatives versus those not on prescribed seda-
tives (12.8 ± 12.6 vs. 3.9 ± 4.4; p < 0.05). 
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 The mean global stress-coping score was below zero, 
reflecting higher levels of stress than the coping scores, 
but in the ‘sufficient’ range. The relatively low mean social 
support score was close to the ‘sufficient’ range, and the 
life meaning score was evaluated as ‘good’.
 Correlations between the MLR and Psychosocial 
Factors, Neuroendocrine and Inflammatory 
Parameters 
 Bivariate Analysis 
 Table 2 shows that patients with higher MLR values 
had significantly higher concentrations of CgA, LL-37, 
IL-6 and CRP (all p values <0.03), showing mostly large 
effects. 
 Multivariate Analysis 
 After controlling for age, sex and BMI (and addition-
ally for proton-pump inhibitor intake and NYHA grade 
for CgA), the significance and effect sizes of the associa-
tions between the MLR and CgA and LL-37 considerably 
increased (r > 0.6, p = 0.003, power >0.95); in contrast, in 
the case of IL-6 and CRP, these values decreased or were 
not remarkably altered (r > 0.45, p < 0.04, power >0.65). 
With additional adjustment for sedative use, higher MLR 
was associated with greater depressive symptom severity, 
showing a large effect (r > 0.6, p = 0.004, power >0.95). 
Similarly to the bivariate analysis, plasma cortisol and the 
2 elected coping subscales (i.e. social support and purpose 
and connection) did not show a significant correlation 
with the MLR. For illustrative purposes, the significant 
multivariate-adjusted correlations between the MLR and 
PNI markers are shown in the online supplementary fig-
ures (see www.karger.com/doi/10.1159/000443835 for all 
online suppl. material). 
 Correlations amongst Psychosocial Factors and 
Neuroendocrine and Inflammatory Markers 
 As can be seen in  table 3 , significant and large effects 
were observed for the association between lower social 
support scores and higher CgA levels and between lower 
 Table 1.  Characteristics of the 23 patients with stable CAD
Parameter Value Ref. range
Leukocyte panel total leukocyte count, G/l 6.73 ± 1.22 3.7 – 9.5
neutrophil granulocyte count, G/l 4.05 ± 1.04 1.7 – 6.1
neutrophil granulocyte fraction, % 59.70 ± 6.86 44 – 68
monocyte count, G/l 0.58 ± 0.23 0.2 – 0.6
monocyte fraction, % 8.68 ± 2.97a 5 – 7
lymphocyte count, G/l 1.90 ± 0.41 1.0 – 3.2
lymphocyte fraction, % 28.82 ± 6.30 27 – 34
MLR 0.32 ± 0.14 0.19b
Lipid panel total cholesterol, mmol/l 4.30 ± 1.35 <5.2
HDL-cholesterol, mmol/l 1.18 ± 0.32 >1.0
LDL-cholesterol, mmol/l 2.27 ± 0.94 <3.0
triglycerides, mmol/l 2.04 ± 1.25a <2.0
Neuroendocrine markers cortisol, nmol/l 294.45 ± 88.59 160 – 620
CgA, ng/ml 178.81 ± 105.50a 23 – 153
Inflammatory markers LL-37, ng/ml 55.31 ± 12.44 25 – 250
IL-6, pg/ml 1.83 ± 1.35 <8.7 
CRP, mg/l 4.93 ± 5.27 <5.0
Psychosocial scores BDI 7.4 ± 9.4 see Methods
BSCI
Global stress-coping     –0.7 ± 4.2   see Methods
Social support 7.9 ± 2.4 see Methods
Purpose and connection 11.9 ± 1.9 see Methods
 Variables are means ± SD. There were 22 patients in the sample for the LDL-cholesterol, cortisol and LL-37 
measurements. a  Values greater than the maximal reference range. b Here we used the ratio of the median values 
of the monocyte and lymphocyte reference ranges (counts).
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life meaning scores and higher CRP levels, both in the bi-
variate and multivariate analysis (r < –0.45, all p values 
<0.04, power >0.65). In addition, more severe depressive 
symptoms significantly correlated with higher LL-37 lev-
els (r > 0.5, p < 0.04, power >0.7) and particularly with 
elevated CgA concentrations (r > 0.6, p < 0.01, power 
>0.9) in the multivariate analysis.
 Discussion 
 The main finding of our study is that an elevated MLR 
was associated with depressive symptoms and increased 
neuroendocrine-sympathetic activity (marked by CgA) 
in patients with stable CAD. Furthermore, enhanced neu-
roendocrine-sympathetic activity correlated with elevat-
ed depressive symptom levels and decreased social sup-
port. 
 We showed an increased monocyte fraction and ele-
vated MLR in our stable CAD patients, reflecting an in-
flammatory state. In support of this, the MLR correlated 
with circulating levels of LL-37, IL-6 and CRP. Surpris-
ingly, the reciprocal of the patients’ MLR value (1/0.32 = 
3.125) is almost equal to the critical lymphocyte-to-
monocyte ratio of 3.1 that has been found in patients with 
a high risk of severe (atherosclerotic) limb ischemia, 
which by itself is frequently associated with CAD  [29] .
 The increased plasma CgA levels could indicate gen-
eral neuroendocrine overactivity including elevated sym-
pathoadrenal activity  [41, 42] ; importantly , we controlled 
for the myocardial release of CgA (in cardiac pressure/
volume overload) and the effect of proton-pump inhibi-
 Table 2.  Correlations between the MLR and PNI system markers in 23 stable CAD patients
Bivariate correlations  Multivariate correlations
r p power  r p power
Cortisol 0.279 n.s. 0.254 0.277 n.s. 0.251
CgA 0.462* 0.026 0.664 0.660** 0.003 0.980
LL-37 0.537** 0.010 0.811 0.643** 0.003 0.963
IL-6 0.620** 0.002 0.951 0.532* 0.016 0.819
CRP 0.474* 0.022 0.692 0.470* 0.036 0.683
BDI 0.216 n.s. 0.173 0.624** 0.004 0.954
BSCI social support 0.221 n.s. 0.180 –0.260 n.s. 0.234
BSCI life meaning –0.124 n.s. 0.088 –0.084 n.s. 0.067
   In the multivariate analysis, all parameters were adjusted for age, BMI and sex. Additional adjustments  were: 
intake of proton-pump inhibitors and grades of heart failure (CgA) and intake of sedatives (BDI). There were 22 
patients in the sample for the cortisol and LL-37 measurements. r = Pearson’s correlation coefficient; n.s. = not 
significant at the level of α = 0.05. * p < 0.05, ** p ≤ 0.01.
 Table 3.  Correlations amongst psychological/psychosocial factors and neuroendocrine and inflammatory mark-
ers in 23 stable CAD patients
Bivariate correlations  Multivariate correlations
r p power  r p power
BDI – CgA 0.275 n.s. 0.258 0.618** 0.008 0.949
BDI – LL-37 0.380 n.s. 0.45 0.502* 0.034 0.736
BSCI social support – CgA –0.502* 0.015 0.756 –0.511* 0.030 0.776
BSCI life meaning – CRP –0.555** 0.006 0.862 –0.467* 0.038 0.676
 In the multivariate analysis, all parameters were adjusted for age, BMI and sex. Additional adjustments were: 
intake of proton-pump inhibitors and grades of heart failure (CgA) and intake of sedatives (BDI). r = Pearson’s 
correlation coefficient; n.s. = not significant at the level of α = 0.05. * p < 0.05, ** p < 0.01
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tors. Recent research with ApoE – / – mice shows height-
ened sympathetic activity to be directly related to mono-
cytosis via the release of hematopoietic cells from the 
bone marrow (mediated by norepinephrine and β3-
adrenergic receptors), followed by increased monocyto-
poiesis in the spleen  [43] . Monocyte delivery to the blood-
stream could result in the progression of atherosclerosis 
through the kindling of inflammation, particularly in the 
wake of myocardial infarction  [43, 44] . Similarly, elevated 
plasma CgA could indicate sympathetic activation capa-
ble of inducing blood monocytosis. This might help to 
explain the significant correlation between CgA and 
MLR, showing a large effect. In turn, activated mono-
cytes/macrophages may also release chromogranins  [45] . 
 About 30% of our patients had clinically relevant levels 
of depressive symptoms, and the global stress-coping 
score was, on average, ‘sufficient’ only, thereby suggesting 
that our sample endorsed limited coping skills under 
stress. The more severely depressed our patients were, the 
higher were their CgA plasma concentrations, suggesting 
that increased activity of the neuroendocrino-sympatho-
adrenal system accompanies depressive symptomatolo-
gy. This corresponds to previous studies in individuals 
with depression and chronic stress who showed sympa-
thoadrenal hyperactivity, which, further downstream, 
could lead to the activation of monocytes/macrophages 
via β-adrenergic receptors, as has been shown in CAD  [4, 
46] . 
Furthermore, proinflammatory cytokines (especially 
IL-1) secreted by activated monocytes/macrophages 
could underlie the link between the MLR and depressive 
symptoms in our study; proinflammatory cytokines fa-
cilitate the development of depressive mood by interfer-
ing with neurotransmitter functioning  [47, 48] . Associa-
tions of MLR with IL-6 and CRP support the importance 
of activated monocytes in the production of IL-6, the 
most important inducer of CRP synthesis and acute-
phase response, in general  [11] . Notably, IL-6 and CRP 
are proposed to be major factors linking stress/depression 
and CAD  [2, 11, 46] . According to a recent study, CAD 
patients with depression exhibit significantly higher CRP 
and lower plasma cortisol levels than nondepressed CAD 
patients  [49] . Similarly, our patients were also character-
ized by relatively high CRP values and relatively low plas-
ma cortisol, perhaps a consequence of long-term negative 
feedback in chronic stress  [49, 50] .
 In our study, depressive symptoms were significantly 
associated with LL-37 which is also deemed to be an in-
flammatory marker; this supports the notion of a possible 
link between inflammation and depression  [14] . In fact, 
LL-37 exerts a multitude of antimicrobial and immuno-
modulatory effects, along with playing a role in apoptosis 
and wound healing; it is expressed widely by different leu-
kocytes  [51] . Since monocytes and related macrophages 
in atherosclerotic lesions abundantly release LL-37, the 
observed correlation of MLR with LL-37 in stable CAD is 
not surprising  [15, 16] .
 The correlation of the low social support score with 
increased CgA presumably indicates that elevated sympa-
thoadrenal activity could be a consequence of psychoso-
cial stress that may be due to limited emotional/social 
support  [52] . Friedler et al.  [53] propose (mainly on the 
basis of investigations using rodent models) that the in-
creased sympathetic activity related to chronic psychoso-
cial stress (like social isolation) could drive hematopoiesis 
towards the formation of monocytic/granulocytic pro-
genitor cells in bone marrow through β-adrenergic recep-
tor-mediated signaling and altered gene expression. This 
idea complements the above-mentioned mechanism of 
monocytosis  [43, 44] .
 Our study has several limitations, foremost being the 
small sample size and the cross-sectional design, prevent-
ing causal inferences. However, the effect sizes of the sta-
tistically significant correlations were large and thus sup-
port the validity of our results. To avoid model overfitting 
in the multivariate analysis, we were unable to control for 
additional covariates, namely established cardiovascular 
risk factors like diabetes and smoking or for medications 
(except for proton-pump inhibitors and sedatives in 2 
models). The average depressive symptom score was in 
the normal range for 70% of our patients, so if our find-
ings would hold in a sample of more severely depressed 
CAD patients remains unclear. Due to the lack of a con-
trol group, we cannot exclude the possibility that similar 
associations of MLR with psychological and psychosocial 
factors and neuroendocrine and inflammatory markers 
also exist in healthy individuals. However, the elevated 
monocyte fraction and MLR values, the overactivated 
neuroendocrine-sympathetic system (marked by in-
creased CgA level) and the low social support score dem-
onstrate pathological characteristics in  our patients. 
 Our findings parallel the observations according to 
which depressed and/or stressed patients with an activated 
sympathetic nervous system are characterized by a chron-
ic inflammatory state that could lead to CAD and/or its 
progression  [4, 46, 54] . Our results also support findings 
on the importance of sympathetic activity in monocytosis 
and in monocyte activation, and on the significance of the 
psychosocial risk factors of CAD (like limited social sup-
port) in promoting stress. By integrating all of this reason-
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ing, the following simplified picture of a vicious cycle/net-
work seems to emerge: a low level of social support results 
in stress with predominant sympathetic activation, which 
then initiates increased monocyte count and activity, 
monocyte secretion of proinflammatory cytokines (with 
the associated low-grade systemic inflammation) facili-
tates the development of CAD and/or depression and this 
may further enhance the activity of the PNI network (e.g. 
via chest pain and stress in angina pectoris). Although not 
tested here, our results suggest that psychosocial interven-
tions targeted at, for instance, reducing chronic stress, im-
proving social support and alleviating depressive symp-
toms, could favorably affect the vicious cycle of interacting 
psychosocial factors and neuroendocrine and inflamma-
tory markers, thereby improving both the mental and 
physical health of CAD patients  [52, 55] .
 To conclude, our study revealed that the MLR, an in-
expensive and easily accessible laboratory measure, may 
be employed as a PNI correlate marker in the routine clin-
ical monitoring of patients with stable CAD. Further in-
vestigations in this multidisciplinary field are required to 
elucidate the detailed functional connections of the PNI 
network in CAD that could facilitate the prevention and 
treatment of atherosclerosis in the future through inno-
vative means.
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